FDA.reportPublic FDA data

lamotrigine 200 MG Oral Tablet [Subvenite]

RxCUI
2003801
RxNorm name
lamotrigine 200 MG Oral Tablet [Subvenite]
Display name
lamotrigine 200 MG Oral Tablet [Subvenite]
Full name
lamotrigine 200 MG Oral Tablet [Subvenite]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SUBVENITELAMOTRIGINEOWP Pharmaceuticals, Inc.7ad18b68-ba16-4810-9c3e-27fa970454e82026-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2003801

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7ad18b68-ba16-4810-9c3e-27fa970454e8Subvenite 200 MG Oral Tablet [PSN] · lamotrigine 200 MG Oral Tablet [Subvenite] [SBD] · Subvenite 200 MG Oral Tablet [SY]315These highlights do not include all the information needed to use SUBVENITE safely and effectively. See full prescribing information for SUBVENITE. SUBVENITE (lamotrigine) tablets, for oral use Initial U.S. Approval: 199420260327